Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +4.07% | 0.00% | +9.40% |
13/05 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
09/05 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.40% | 9.19Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Wedbush Removes Outperform-Rated Clearside Biomedical From Best Ideas List; Price Target is $9